State Street’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-4,822
| Closed | -$28.8K | – | 4288 |
|
2024
Q4 | $28.8K | Hold |
4,822
| – | – | ﹤0.01% | 4191 |
|
2024
Q3 | $47.1K | Sell |
4,822
-2,975
| -38% | -$29K | ﹤0.01% | 4112 |
|
2024
Q2 | $160K | Sell |
7,797
-21,260
| -73% | -$435K | ﹤0.01% | 3880 |
|
2024
Q1 | $1.31M | Buy |
29,057
+1,536
| +6% | +$69.3K | ﹤0.01% | 3400 |
|
2023
Q4 | $1.3M | Buy |
27,521
+1,905
| +7% | +$89.9K | ﹤0.01% | 3425 |
|
2023
Q3 | $1.04M | Sell |
25,616
-103,896
| -80% | -$4.21M | ﹤0.01% | 3522 |
|
2023
Q2 | $13.8M | Buy |
129,512
+19,469
| +18% | +$2.07M | ﹤0.01% | 2465 |
|
2023
Q1 | $32.9M | Buy |
110,043
+87,007
| +378% | +$26M | ﹤0.01% | 1911 |
|
2022
Q4 | $7.92M | Sell |
23,036
-69
| -0.3% | -$23.7K | ﹤0.01% | 2834 |
|
2022
Q3 | $4.37M | Buy |
23,105
+276
| +1% | +$52.2K | ﹤0.01% | 3132 |
|
2022
Q2 | $4.82M | Sell |
22,829
-64,718
| -74% | -$13.7M | ﹤0.01% | 3122 |
|
2022
Q1 | $29.3M | Buy |
87,547
+3,478
| +4% | +$1.16M | ﹤0.01% | 2125 |
|
2021
Q4 | $27.3M | Buy |
84,069
+1,032
| +1% | +$336K | ﹤0.01% | 2237 |
|
2021
Q3 | $40.3M | Sell |
83,037
-8,158
| -9% | -$3.96M | ﹤0.01% | 1969 |
|
2021
Q2 | $42.4M | Buy |
91,195
+11,451
| +14% | +$5.32M | ﹤0.01% | 1973 |
|
2021
Q1 | $55.1M | Sell |
79,744
-24,881
| -24% | -$17.2M | ﹤0.01% | 1672 |
|
2020
Q4 | $77.3M | Buy |
104,625
+23,759
| +29% | +$17.6M | ﹤0.01% | 1353 |
|
2020
Q3 | $56.1M | Buy |
80,866
+19,967
| +33% | +$13.9M | ﹤0.01% | 1372 |
|
2020
Q2 | $51.7M | Buy |
60,899
+53,012
| +672% | +$45M | ﹤0.01% | 1445 |
|
2020
Q1 | $2.82M | Buy |
7,887
+1,640
| +26% | +$586K | ﹤0.01% | 2905 |
|
2019
Q4 | $1.46M | Buy |
6,247
+946
| +18% | +$221K | ﹤0.01% | 3339 |
|
2019
Q3 | $597K | Buy |
5,301
+1,292
| +32% | +$146K | ﹤0.01% | 3478 |
|
2019
Q2 | $526K | Buy |
+4,009
| New | +$526K | ﹤0.01% | 3504 |
|